In chronic myeloid leukemia, the YBX3 was shown to be a regulator of proliferation in the CML cell line through the PI3K/AKT/Bcr/Abl pathway (37). Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.